Results from a 12-year study have determined that the UroLume® Urethral Stent from AMS is a safe and effective long-term therapy for symptomatic BPH. ¹
¹Masood S, Djaladat H, Kouriefs C, Keen M, Palmer JH. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. BJU Int Dec. 2004 v. 94(9)p. 1271-4.
|
